Endocyte, Inc. Debt to Equity Ratio 2011-2018 | ECYT
Current and historical debt to equity ratio values for Endocyte, Inc. (ECYT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Endocyte, Inc. debt/equity for the three months ending September 30, 2018 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-09-30 | $0.01B | $0.35B | 0.02 |
| 2018-06-30 | $0.01B | $0.17B | 0.04 |
| 2018-03-31 | $0.01B | $0.17B | 0.03 |
| 2017-12-31 | $0.01B | $0.10B | 0.06 |
| 2017-09-30 | $0.01B | $0.10B | 0.05 |
| 2017-06-30 | $0.01B | $0.12B | 0.05 |
| 2017-03-31 | $0.01B | $0.13B | 0.05 |
| 2016-12-31 | $0.01B | $0.14B | 0.05 |
| 2016-09-30 | $0.01B | $0.15B | 0.04 |
| 2016-06-30 | $0.01B | $0.15B | 0.04 |
| 2016-03-31 | $0.01B | $0.16B | 0.03 |
| 2015-12-31 | $0.01B | $0.17B | 0.04 |
| 2015-09-30 | $0.01B | $0.18B | 0.04 |
| 2015-06-30 | $0.01B | $0.19B | 0.03 |
| 2015-03-31 | $0.01B | $0.20B | 0.03 |
| 2014-12-31 | $0.01B | $0.21B | 0.04 |
| 2014-09-30 | $0.01B | $0.21B | 0.05 |
| 2014-06-30 | $0.02B | $0.22B | 0.08 |
| 2014-03-31 | $0.06B | $0.09B | 0.67 |
| 2013-12-31 | $0.08B | $0.09B | 0.85 |
| 2013-09-30 | $0.09B | $0.09B | 0.96 |
| 2013-06-30 | $0.10B | $0.09B | 1.06 |
| 2013-03-31 | $0.10B | $0.10B | 1.07 |
| 2012-12-31 | $0.12B | $0.10B | 1.15 |
| 2012-09-30 | $0.12B | $0.10B | 1.17 |
| 2012-06-30 | $0.12B | $0.10B | 1.22 |
| 2012-03-31 | $0.02B | $0.10B | 0.17 |
| 2011-12-31 | $0.02B | $0.11B | 0.16 |
| 2011-09-30 | $0.02B | $0.12B | 0.15 |
| 2011-06-30 | $0.02B | $0.07B | 0.28 |
| 2011-03-31 | $0.02B | $0.08B | 0.25 |
| 2010-12-31 | $0.12B | $-0.10B | -1.22 |
| 2010-09-30 | $0.00B | 0.00 | |
| 2010-06-30 | $0.00B | 0.00 | |
| 2010-03-31 | $0.00B | 0.00 | |
